|
EORTC AISBL / IVZW |
|
|
EORTC AISBL / IVZW |
Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background
| 30951 | Randomized phase II trial of Interferon alpha-2a with and without 13-cis Retinoic Acid in patients with progressive metastatic renal cell carcinoma Amendment protocol: Extension to a randomized phase III trial |
| 30947 | A randomized comparison of nephrectomy followed by Interferon Alpha 2-b (Intron-A) vs Interferon Alpha 2-b (Intron-A) alone in patients with advanced renal cell carcinoma. Phase III |
| 30923 | Phase II trial of the efficacy and safety of roquinimex (linomide) in the treatment of renal cell carcinoma |
| 04892 | Essais cliniques phase II d'une nouvelle nitrosour‚e: la Cyst‚mustine dans les m‚lanomes et les reins |
| 30905 | Phase II trial of the efficacy and safety of linomide in the treatment of renal cell carcinoma |
| 04891 | Essais cliniques phase II d'une nouvelle nitrosourée: la Cystémustine dans les poumons, les adénocarcinomes colo-rectaux, les gliomes, les mélanomes, les reins, les sarcomes des parties molles et les tumeurs de la tête et du cou. |
| 30885 | Randomized phase III study with recombinant interferon alpha and recombinant interferon alpha and gamma in patients with advanced renal cell carcinoma |
| 24873 | PHASE II STUDY OF PIRARUBICIN (THP) IN PATIENTS WITH ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK. |
| 30882 | Phase II study of vinblastine in patients with progressive measurable matastatic renal cell carcinoma |
| 16871K | Phase II study of duP 785 (NSC 368390) in patients with advanced renal adenocarcinoma |
| 16864F | Phase II protocol to study the antitumor activity of flavone acetic acid (NSC 347512 - FAA LM 975) in patients with advanced renal adenocarcinoma |
| 30872 | PHASE II TRIAL OF TCNU IN PROGRESSIVE MEASURABLE METASTATIC RENAL CANCER - |
| 16861 | PHASE II STUDY OF HUMAN RECOMBINANT Interferon-GAMMA (rIFN-Y) IN ADVANCED RENAL ADENOCARCINOMA . |
| 04861 | Etude clinique phase II 4' -0-tetrahydropyranyl adriamycine (THP-ADM-1609 RB) |
| 30866 | PHASE II STUDY OF MITOZOLOMIDE IN ADVANCED RENAL CANCER |
| 16891K | Phase II trial of CL286,558 in patients with renal cell cancer |
| 30012 | A Randomised Controlled Trial of Interferon-alpha, Interleukin-2 and 5-Fluorouracil vs Interferon-alpha Alone in Patients with Advanced Renal Cell Carcinoma. |
| 30881 | Phase III trial of the investigation of the potentially curative value of lymphadenectomy in conjunction with radical nephrectomy for non-metastatic renal cell carcinoma |
| 30955 | Phase III adjuvant trial:Interleukin-2, Interferon-alpha and 5-Fluorouracil for patients with high risk of relapse after surgical treatment for RCC |
| 30904 | A Prospective Randomized Ohase III study Comparing Radical Surgery to Elective Kidney Sparing Surgery for Low Stage Renal Cell Carcinoma |
| 30073 | Randomized Phase III trial comparing immediate versus deferred nephrectomy in patients with synchronous metastatic renal cell carcinoma. |
| 30072 | A Phase III Randomised Double-blind Study Comparing Sorafenib With Placebo In Patients With Resected Primary Renal Cell Carcinoma at High or Intermediate Risk of Relapse |
| 16921K | Phase II trial with Taxotere in patients with advanced renal adenocarinoma |